271 related articles for article (PubMed ID: 24168367)
21. Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.
Liraz-Zaltsman S; Yaka R; Shabashov D; Shohami E; Biegon A
J Mol Neurosci; 2016 Sep; 60(1):46-62. PubMed ID: 27421842
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal immediate early gene transcription in the rat fluid percussion traumatic brain injury model.
Wang Y; Hameed MQ; Rakhade SN; Iglesias AH; Muller PA; Mou DL; Rotenberg A
Neuroreport; 2014 Aug; 25(12):954-9. PubMed ID: 24978397
[TBL] [Abstract][Full Text] [Related]
23. Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury.
Smith DH; Okiyama K; Thomas MJ; McIntosh TK
J Neurosci; 1993 Dec; 13(12):5383-92. PubMed ID: 8254381
[TBL] [Abstract][Full Text] [Related]
24. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
Muir KW
Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
[TBL] [Abstract][Full Text] [Related]
25. Gallic acid improved behavior, brain electrophysiology, and inflammation in a rat model of traumatic brain injury.
Sarkaki A; Farbood Y; Gharib-Naseri MK; Badavi M; Mansouri MT; Haghparast A; Mirshekar MA
Can J Physiol Pharmacol; 2015 Aug; 93(8):687-94. PubMed ID: 26222320
[TBL] [Abstract][Full Text] [Related]
26. A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.
Dhawan J; Benveniste H; Luo Z; Nawrocky M; Smith SD; Biegon A
Future Neurol; 2011 Nov; 6(6):823-834. PubMed ID: 22140354
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective efficiency of NMDA receptor blockade in the striatum and CA3 hippocampus after various durations of cerebral ischemia in gerbils.
Radenovic L; Selakovic V; Janac B; Andjus PR
Acta Physiol Hung; 2011 Mar; 98(1):32-44. PubMed ID: 21388929
[TBL] [Abstract][Full Text] [Related]
28. Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury.
Yang LY; Chu YH; Tweedie D; Yu QS; Pick CG; Hoffer BJ; Greig NH; Wang JY
Exp Neurol; 2015 Jul; 269():56-66. PubMed ID: 25819102
[TBL] [Abstract][Full Text] [Related]
29. D-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus.
Portero-Tresserra M; Del Olmo N; Martí-Nicolovius M; Guillazo-Blanch G; Vale-Martínez A
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1798-807. PubMed ID: 25453488
[TBL] [Abstract][Full Text] [Related]
30. Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats.
Pitkänen A; Immonen R; Ndode-Ekane X; Gröhn O; Stöhr T; Nissinen J
Epilepsy Res; 2014 May; 108(4):653-65. PubMed ID: 24636248
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of MK-801 against traumatic brain injury in immature rats.
Sönmez A; Sayın O; Gürgen SG; Çalişir M
Neurosci Lett; 2015 Jun; 597():137-42. PubMed ID: 25943283
[TBL] [Abstract][Full Text] [Related]
32. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
[TBL] [Abstract][Full Text] [Related]
33. Dexmedetomidine prevents post-ischemic LTP via presynaptic and postsynaptic mechanisms.
Zhou L; Qin SJ; Gao X; Han JP; Hu B; Li M; Wu YQ; Ma X; Gu SL; Ma TF
Brain Res; 2015 Oct; 1622():308-20. PubMed ID: 26168895
[TBL] [Abstract][Full Text] [Related]
34. Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury.
Temple MD; Hamm RJ
Brain Res; 1996 Nov; 741(1-2):246-51. PubMed ID: 9001729
[TBL] [Abstract][Full Text] [Related]
35. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats.
Gomes FV; Kakihata AM; Semedo AC; Hott SC; Uliana DL; Guimarães FS; Resstel LB
Behav Brain Res; 2014 Sep; 271():374-9. PubMed ID: 24931794
[TBL] [Abstract][Full Text] [Related]
36. Activated Src kinases interact with the N-methyl-D-aspartate receptor after neonatal brain ischemia.
Jiang X; Mu D; Biran V; Faustino J; Chang S; Rincón CM; Sheldon RA; Ferriero DM
Ann Neurol; 2008 May; 63(5):632-41. PubMed ID: 18384166
[TBL] [Abstract][Full Text] [Related]
37. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
Ikonomidou C; Turski L
Lancet Neurol; 2002 Oct; 1(6):383-6. PubMed ID: 12849400
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats.
Rao VL; Dogan A; Todd KG; Bowen KK; Dempsey RJ
Brain Res; 2001 Aug; 911(1):96-100. PubMed ID: 11489449
[TBL] [Abstract][Full Text] [Related]
39. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with excitatory amino acid antagonist drugs.
Muir KW; Lees KR
Stroke; 1995 Mar; 26(3):503-13. PubMed ID: 7886734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
